Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A roadmap toward promoting and improving brain health in Europe and closing the awareness and funding gap

PAJM. Boon, T. Berger, M. Leonardi, T. Marson, U. Kallweit, E. Moro, A. Toscano, I. Rektorova, A. Accorroni, C. Scheerens, A. Boesch, M. Crean, A. Sander, S. Lee, CLA. Bassetti

. 2025 ; 32 (1) : e16589. [pub] -

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010399

BACKGROUND AND PURPOSE: The global burden of neurological diseases exceeds 43.1%, imposing a significant burden on patients, caregivers and society. This paper presents a roadmap to reduce this burden and improve brain health (BH) in Europe. METHODS: The roadmap is based on the European Academy of Neurology's (EAN) five-pillar BH strategy: advancing a global BH approach (P1), supporting policymaking (P2), fostering research (P3), promoting education (P4), and raising awareness of prevention and treatment (P5). It reviews current efforts, collaborations and future directions aligned with the WHO Intersectoral Global Action Plan (iGAP) for Neurological Disorders and suggests future initiatives and call for action. RESULTS: P1: Support WHO-iGAP through defined action points, international collaborations, in particular, the WHO BH Unit, and the EAN Brain Health Mission. P2: Collaborate with 48 national neurological societies to promote National Brain Plans (NBPs), addressing local needs, and improving access to care. P3: Advocate for more research funding; identify determinants of BH; develop preventive measures. P4: Provide educational opportunities for neurologists, public education programs, and advocacy training, including tools to educate the public. P5: Spearhead global awareness campaigns, organize public educational activities, and train BH advocates to contribute toward sustainable and long-term public health campaigns and policy engagement. CONCLUSIONS: The paper highlights the importance of a unified approach, integrating international collaborations and local initiatives, to improve BH outcomes based on the WHO-iGAP, and support sustainable development goals, in particular SDG 3: Good Health and Well-being and SDG 4: Quality Education.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010399
003      
CZ-PrNML
005      
20250429134609.0
007      
ta
008      
250415s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ene.16589 $2 doi
035    __
$a (PubMed)39815708
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Boon, Paul A J M $u Department of Neurology & 4Brain, Ghent University Hospital, Ghent, Belgium $u Eindhoven University of Technology, Eindhoven, The Netherlands $u European Academy of Neurology, Vienna, Austria $1 https://orcid.org/0000000241808896
245    12
$a A roadmap toward promoting and improving brain health in Europe and closing the awareness and funding gap / $c PAJM. Boon, T. Berger, M. Leonardi, T. Marson, U. Kallweit, E. Moro, A. Toscano, I. Rektorova, A. Accorroni, C. Scheerens, A. Boesch, M. Crean, A. Sander, S. Lee, CLA. Bassetti
520    9_
$a BACKGROUND AND PURPOSE: The global burden of neurological diseases exceeds 43.1%, imposing a significant burden on patients, caregivers and society. This paper presents a roadmap to reduce this burden and improve brain health (BH) in Europe. METHODS: The roadmap is based on the European Academy of Neurology's (EAN) five-pillar BH strategy: advancing a global BH approach (P1), supporting policymaking (P2), fostering research (P3), promoting education (P4), and raising awareness of prevention and treatment (P5). It reviews current efforts, collaborations and future directions aligned with the WHO Intersectoral Global Action Plan (iGAP) for Neurological Disorders and suggests future initiatives and call for action. RESULTS: P1: Support WHO-iGAP through defined action points, international collaborations, in particular, the WHO BH Unit, and the EAN Brain Health Mission. P2: Collaborate with 48 national neurological societies to promote National Brain Plans (NBPs), addressing local needs, and improving access to care. P3: Advocate for more research funding; identify determinants of BH; develop preventive measures. P4: Provide educational opportunities for neurologists, public education programs, and advocacy training, including tools to educate the public. P5: Spearhead global awareness campaigns, organize public educational activities, and train BH advocates to contribute toward sustainable and long-term public health campaigns and policy engagement. CONCLUSIONS: The paper highlights the importance of a unified approach, integrating international collaborations and local initiatives, to improve BH outcomes based on the WHO-iGAP, and support sustainable development goals, in particular SDG 3: Good Health and Well-being and SDG 4: Quality Education.
650    _2
$a lidé $7 D006801
650    12
$a nemoci nervového systému $x terapie $7 D009422
650    _2
$a podpora zdraví $7 D006293
650    _2
$a mozek $7 D001921
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Berger, Thomas $u Department of Neurology and Comprehensive Center of Clinical Neurosciences & Mental Health, Medical University of Vienna, Vienna, Austria
700    1_
$a Leonardi, Matilde $u Neurology, Public Health, Disability Unit and Coma Research Centre, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy
700    1_
$a Marson, Tony $u Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
700    1_
$a Kallweit, Ulf $u Center for Narcolepsy and Hypersomnias, Professorship for Narcolepsy and Hypersomnolence Research, Faculty of Health, University Witten/Herdecke, Witten, Germany $1 https://orcid.org/0000000319756919
700    1_
$a Moro, Elena $u Grenoble Alpes University, CHU of Grenoble, Division of Neurology, Grenoble institute of Neurosciences, Grenoble, France
700    1_
$a Toscano, Antonio $u ERN-NMD Center for Neuromuscular Disorders of Messina, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
700    1_
$a Rektorova, Irena $u Brain and Mind Research, Central European Institute of Technology, Masaryk University, Brno, Czechia $u First Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czechia $1 https://orcid.org/0000000254554573
700    1_
$a Accorroni, Alice $u Hôpitaux Universitaires de Genève, Geneva, Switzerland
700    1_
$a Scheerens, Charlotte $u Department of Public Health and Primary Care, Ghent University, Belgium and United Nations University-CRIS, Bruges, Belgium
700    1_
$a Boesch, Antonia $u European Academy of Neurology, Vienna, Austria
700    1_
$a Crean, Michael $u European Academy of Neurology, Vienna, Austria
700    1_
$a Sander, Anja $u European Academy of Neurology, Vienna, Austria
700    1_
$a Lee, Simon $u European Academy of Neurology, Vienna, Austria
700    1_
$a Bassetti, Claudio L A $u Department of Neurology, Inselspital, University of Bern, Bern, Switzerland
773    0_
$w MED00001629 $t European journal of neurology $x 1468-1331 $g Roč. 32, č. 1 (2025), s. e16589
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39815708 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134605 $b ABA008
999    __
$a ok $b bmc $g 2311636 $s 1247480
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 32 $c 1 $d e16589 $e - $i 1468-1331 $m European journal of neurology $n Eur J Neurol $x MED00001629
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace